✦ LIBER ✦

Vorapaxar, an oral PAR-1 receptor antagonist, does not affect the pharmacokinetics and pharmacodynamics of warfarin

✍ Scribed by Kosoglou, Teddy; Zhu, Yali; Xuan, Fengjuan; Black, Laura; Johnson-Levonas, Amy O.; Martinho, Monika; Statkevich, Paul; Cutler, David L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irbesartan does not affect the steady-st

✍ B. Mangold; W. Gielsdorf; M. R. Marino 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 96 KB

Pharmacodynamics and pharmacokinetics of

✍ Teddy Kosoglou; Larisa Reyderman; Renger G. Tiessen; André A. van Vliet; Robert 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 504 KB

Tegaserod does not significantly affect

✍ Patricia Ledford; Nicki On; Monica Ligueros-Saylan; Joelle Campestrini; Stuart O 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Pharmacokinetics and pharmacodynamics of

✍ Kosoglou, Teddy; Kraft, Walter K.; Kumar, Bharath; Statkevich, Paul; Xuan, Fengj 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 221 KB

PHARMACODYNAMICS OF VORAPAXAR, A PLATELE

✍ Lisa K. Jennings; David Moliterno; Robert Storey; Edward Hord; Jayaprakash Kotha 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Food does not affect the pharmacokinetic

✍ Taisuke Uchida; Walter J. Krauwinkel; Hans Mulder; Ronald A. Smulders 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB